Note: You must complete a short online consultation so that our doctor can ensure that the treatment is suitable for you. The above pricing should only be used as a reference. The final decision to issue this treatment lies with the prescribing doctor.
Vaniqa is a prescription medication in the form of a cream that can be applied to areas of skin that are affected by excess facial hair. It has been clinically proven to reduce the appearance of unwanted hair and slowing down regrowth to make it easier to manage.
Once Vaniqa is applied to hair follicles, it interacts with these follicles, resulting in slower hair growth on and around the area that the cream has been applied to.
This medicine is used by women to lessen the growth of unwanted hair. When Vaniqa is applied, it does not permanently eliminate the growth of facial hair. However, this medicine can be used to help manage the growth of unwanted hair and improve your appearance overall. For many women, this can help improve their confidence and reduce the need for expensive permanent expensive treatments or having to manage regrowth every day.
You can buy a 60g tub of Vaniqa online at euroClinix in a dose of 11.5%.
Vaniqa cream has been clinically tested and proven to effectively treat excessive facial hair growth in women within four to six weeks of use. Because it's a topical cream, applying the medication to the desired area is particularly easy and will ensure the relevant skin surface is treated. This will also isolate side effects to a single area if they should arise. It's also much cheaper than methods such as laser treatments or electrolysis and has a very low risk of side effects in comparison.
This medicine is clinically proven to decrease the growth of unwanted facial hair. Results can take from 4-8 weeks to appear, if this prescription is used twice a day, at least 8 hours apart. Please bear in mind that individual results may vary.
It is advised that you continue with your standard procedures for hair removal until anticipated results have been attained.
Vaniqa's active ingredient eflornithine affects the enzyme ornithine decarboxylase to treat excessive facial hair growth. This enzyme is responsible for making hair grow, as it is located inside the follicles themselves, and by blocking it from fully functioning hair growth is slowed down to a rate that is more manageable over longer periods of time.
Vaniqa has been proven clinically to provide a short and longer term solution to excess hair growth symptoms in women. As it is applied topically and straight to the affected area other hair growth such as on the head and eyebrows will not be affected. This medication should not be used during pregnancy because it is not yet medically proven to be suitable for use during this time.
You should not use this medicine if you are or have been allergic to it in the past. Vaniqa falls into the MHRA pregnancy category C. This means that it is not medically proven whether eflornithine will harm an unborn baby or not.
Vaniqa should be used twice per day by applying a thin layer of the cream to the desired area of skin. It's advisable that the treatment has an eight-hour break between applications if possible and you should ensure the skin is clean and dry before use. If at any point you experience skin irritation you should reduce the amount of applications to once per day or in quantity, and if this still continues consult your doctor for more information.
Vaniqa is dispensed in a tub, which should last between four and six weeks. Most women will notice an improvement within that time, although in some cases it may take up to eight weeks. If the cream is still not effective after four months of use you should contact your doctor.
You should not use this medicine if you are or have been allergic to it in the past. Vaniqa falls into the FDA pregnancy category C. This means that it is not medically proven whether eflornithine will harm an unborn baby or not. Before taking this medicine, it is advised that you consult you doctor about taking this medicine if you are pregnant.
It is also not known whether eflornithine passes into breast milk. So it is advised that you do not use this treatment if you are breast-feeding without first consulting your doctor. This medicine is not suitable to be used by children under 12 years old.
In the unlikely event you do notice any signs of allergic reaction including swelling around the face, lips, mouth tongue or throat you should discontinue use and seek medical attention immediately.
There is a small chance that it may cause some mild side effects, as with all prescription medications. These include irritation to the skin, ingrown hairs, dry skin or cold sores, and changes in skin pigmentation. Although these should be mild or non-existent, if any side effects should continue or worsen you should consult your doctor immediately.
You can buy Vaniqa online at euroClinix after a free, quick and simple consultation.Our doctors use this consultation to gauge your suitability for the treatment before approving a prescription for you. Once your medical information has been deemed appropriate for treatment, your script will be sent to our pharmacy where the Vaniqa cream will be dispensed. Depending on which delivery option you chose during your checkout process, you can buy and receive Vaniqa as early as the next working day.
On orders made before 4.30pm, you will receive your Vaniqa medication the next day. All packages are 100% confidential so you can get Vaniqa delivered to any location in confidence to begin treating hirsutism.
Fill out a short